Bradesco (NYSE: BBD) closes healthcare share merger and reaches 91.35% of Bradsaúde
Rhea-AI Filing Summary
Banco Bradesco S.A. reports that the merger of shares issued by Bradesco Gestão de Saúde S.A. into Bradsaúde S.A. has been approved and completed, confirming the previously defined exchange ratio without adjustments. As a result, Bradesco’s equity interest in Bradsaúde increased to 91.35% of total and voting capital, not considering any potential exercises of withdrawal rights by dissenting Bradsaúde shareholders, whose term runs until May 7, 2026.
The company also notes that an extraordinary general meeting of Mediservice Operadora de Planos de Saúde S.A. is scheduled for May 1, 2026, to approve the contribution of Bradsaúde’s dental plans portfolio and other operational assets and liabilities to Mediservice, which became an indirect subsidiary of Bradsaúde after the merger of shares. Bradesco states it will continue to inform shareholders and the market of material developments.
Positive
- None.
Negative
- None.
Insights
Bradesco consolidates healthcare units, raising its Bradsaúde stake to 91.35%.
Banco Bradesco completed the merger of shares of Bradesco Gestão de Saúde into Bradsaúde, confirming the agreed exchange ratio with no adjustments. This lifts Bradesco’s equity interest in Bradsaúde to 91.35% of total and voting capital, giving it tighter control over its healthcare platform.
The filing also highlights an extraordinary general meeting of Mediservice on May 1, 2026, to approve transferring Bradsaúde’s dental plans portfolio and related operational assets and liabilities to Mediservice. This step organizes healthcare operations under an indirect Bradsaúde subsidiary.
Overall, the actions formalize an internal consolidation of healthcare businesses rather than changing Bradesco’s core banking profile. Future disclosures about the performance of Bradsaúde and Mediservice in upcoming reporting periods may clarify how this structure affects segment results.
Key Figures
Key Terms
extraordinary general meeting regulatory
withdrawal right regulatory
forward-looking statements regulatory
SECURITIES AND EXCHANGE COMMISSION
06029-900 - Osasco - SP
Federative Republic of Brazil
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes _______ No ___X____.
Closing of the Consolidation of Healthcare Businesses – Approval of the Merger of Shares
Banco Bradesco S.A. (“Bradesco”), further to its previous disclosures regarding the consolidation of the healthcare businesses of the Bradesco Organization in Bradsaúde S.A. (current corporate name of Odontoprev S.A.) (“Bradsaúde”), hereby informs its shareholders and the market in general that:
(i) on the date hereof, the merger of shares issued by Bradesco Gestão de Saúde S.A. (“BGS”) into Bradsaúde (“Merger of Shares”) was approved (homologada) and consummated, with the confirmation of the exchange ratio previously established, without adjustments.
Upon the consummation of the Merger of Shares, BGS became a wholly-owned subsidiary of Bradsaúde, and Bradesco’s equity interest in Bradsaúde increased to 91.35% of the total and voting capital (without taking into account any exercises of the withdrawal right by dissenting shareholders of Bradsaúde, the term of which will expire on May 7, 2026)]; and
(ii) as previously disclosed, the extraordinary general meeting of Mediservice Operadora de Planos de Saúde S.A. (“Mediservice”) will be held on May 1, 2026, at which will be approved the contribution of the dental plans portfolio and other operational assets and liabilities of Bradsaúde to Mediservice, which became, as a result of the Merger of Shares, an indirect subsidiary of Bradsaúde.
Without prejudice to further details contained in the disclosures made by Bradsaúde, Bradesco will keep its shareholders and the market in general informed of any material developments, pursuant to the applicable regulations.
Cidade de Deus, Osasco, SP, April 30, 2026.
Banco Bradesco S.A.
André Costa Carvalho
Investor Relations Officer
|
BANCO BRADESCO S.A. | ||
|
By: |
/S/André Costa Carvalho
| |
| André Costa Carvalho Investor Relations Officer | ||
This press release may contain forward-looking statements. These statements are statements that are not historical facts, and are based on management's current view and estimates of future economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.